Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer.
Bernstein ZP, Goldrosen MH, Vaickus L, Friedman N, Watanabe H, Rahman R, Park J, Arbuck SG, Sweeney J, Vesper DS, et al.
Bernstein ZP, et al. Among authors: vesper ds.
J Immunother (1991). 1991 Oct;10(5):383-7. doi: 10.1097/00002371-199110000-00012.
J Immunother (1991). 1991.
PMID: 1665077
Clinical Trial.